Circulating microRNAs as predictors of response to sofosbuvir + daclatasvir + ribavirin in in HCV genotype-4 Egyptian patients.

Hassuna, Noha Anwar; Gamil, Aya Nabil; Mahmoud, Mahmoud Shokry; Mohamed, Wafaa Khairy; Khairy, Rasha

Hassuna, Noha Anwar; Gamil, Aya Nabil; Mahmoud, Mahmoud Shokry; Mohamed, Wafaa Khairy; Khairy, Rasha.

Afiliación

Hassuna NA; Department of Medical Microbiology and Immunology, Faculty of Medicine, Minia University, Minia, Egypt. nohaanwar@mu.edu.eg.
Gamil AN; Department of Medical Microbiology and Immunology, Faculty of Medicine, Minia University, Minia, Egypt.
Mahmoud MS; Department of Medical Microbiology and Immunology, Faculty of Medicine, Minia University, Minia, Egypt.
Mohamed WK; Department of Medical Microbiology and Immunology, Faculty of Medicine, Minia University, Minia, Egypt.
Khairy R; Department of Medical Microbiology and Immunology, Faculty of Medicine, Minia University, Minia, Egypt.

BMC Gastroenterol ; 22(1): 499, 2022 Dec 03.

Article en En | MEDLINE | ID: mdl-36463118

Asunto(s)

MicroARN Circulante; Hepatitis C Crónica; Hepatitis C; MicroARNs; Humanos; Sofosbuvir/uso terapéutico; Ribavirina/uso terapéutico; Antivirales/uso terapéutico; Egipto; Hepatitis C Crónica/tratamiento farmacológico; Hepacivirus/genética; Hepatitis C/tratamiento farmacológico; Genotipo

Palabras clave

Daclatasvir; HCV (genotype-4); Liver fibrosis; MicroRNAs; Sofosbuvir

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatitis C / Hepatitis C Crónica / MicroARNs / MicroARN Circulante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: BMC Gastroenterol Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google